Single User License: Pipeline Review Of Hospital Acquired Pneumonia Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
USD 4315.5
Flat 10% Discount!!
Report will be delivered with in 15-20 working days
Free Customization as per your requirement You will get Custom Report at Syndicated Report price
Request Sample
Buy Now
REPORT DESCRIPTION
Hospital acquired pneumonia (HAP) is a pulmonary infectionthat occurs after 48 hours of hospitalization and it was not present at the time of admission. It is the most-common infection and is usually bacterial in origin. The symptoms of pneumonia are cough, fever, nausea, vomiting, shortness of breath, loss of appetite, decreased blood pressure and high heart rate.HAP is the major cause of high morbidity, mortality and cost.Intubation and mechanical ventilation (MV) are risk factors for developingHAP. The development of new diagnostic tools and therapeutic weapons is urgently needed to face the epidemic of multidrug-resistant pathogens. Read More @ http://www.transparencymarketresearch.com/hospital-acquired-pneumonia-drugs.html Hospital Acquired Pneumonia (HAP) - Pipeline Review, provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Hospital Acquired Pneumonia (HAP), with latest updates. Some of the players involved in the therapeutic development for HAP are AstraZeneca, Cubist Pharmaceuticals, Basilea Pharmaceutica, Melinta Therapeutics, Biota Pharmaceuticals, Aridis Pharmaceuticals, Meiji Seika Pharma, Adenium Biotech and Tetraphase Pharmaceuticals. Scope •
The report provides a snapshot of the global Hospital Acquired Pneumonia Drugs Market.
•
The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
•
The report reviews key players involved in the development of Hospital Acquired Pneumonia Drugs and enlists all their major and minor projects
•
The report summarizes all the dormant and discontinued pipeline projects
•
Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
•
Coverage of the Hospital Acquired Pneumonia Drugs pipeline on the basis of target, MoA, route of administration and molecule type
•
Latest news and deals relating related to pipeline products
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include •
North America
•
Asia Pacific
•
Europe
•
Rest of the World
This report provides comprehensive analysis of •
Market growth drivers
•
Factors limiting market growth
•
Current market trends
•
Market structure
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. Reasons to buy •
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
•
Develop strategic initiatives by understanding the focus areas of leading companies
•
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
•
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
More Reports on Pharmaceutical Market: http://www.transparencymarketresearch.com/pharmaceuticalmarket-reports-1.html About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge. Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Browse Market Research Blogs: http://www.tmrblog.com/ https://marketingfirmblog.wordpress.com